Lemaitre Vascular (LMAT) EBITDA Margin (2010 - 2026)
Lemaitre Vascular (LMAT) reported EBITDA Margin of 26.71% for Q1 2026, up 562.0% year-over-year from 4.03% in Q1 2025, and up 151.71% on a QoQ basis from 51.65% in Q4 2025.
Lemaitre Vascular (LMAT) has 17 years of EBITDA Margin data on file, last reported at 26.71% in Q1 2026.
- Quarterly EBITDA Margin rose 562.0% year-over-year to 26.71% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 8.17% (up 256.0% YoY) and the FY2025 annual result came in at 6.33%, up 89.0% from the prior year.
- EBITDA Margin advanced to 26.71% in Q1 2026 per LMAT's latest filing, from 51.65% in the prior quarter.
- Across five years, EBITDA Margin topped out at 33.27% in Q3 2025 and bottomed at 51.65% in Q4 2025.
- The 5-year median for EBITDA Margin is 20.04% (2022), against an average of 12.92%.
- The widest annual swing landed in 2024, when EBITDA Margin slumped 7016 bps; it then soared 929 bps in 2025.
- Tracing LMAT's EBITDA Margin over 5 years: stood at 17.01% in 2022, then grew by 23 bps to 20.88% in 2023, then tumbled by 336 bps to 49.28% in 2024, then decreased by 5 bps to 51.65% in 2025, then surged by 152 bps to 26.71% in 2026.
- Per Business Quant, the three latest LMAT EBITDA Margin figures stand at 26.71% (Q1 2026), 51.65% (Q4 2025), and 33.27% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn | 28.86% |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn | 1.97% |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn | 34.92% |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn | 20.96% |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn | 4.04% |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn | 19.85% |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn | 13.65% |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn | 2.44% |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn | 17.48% |
| 10 | Lemaitre Vascular | 2.28 Bn | 1.91 Bn | 48.40 Mn | 26.71% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 26.71% |
| Dec 31, 2025 | -51.65% |
| Sep 30, 2025 | 33.27% |
| Jun 30, 2025 | 25.13% |
| Mar 31, 2025 | 21.09% |
| Dec 31, 2024 | -49.28% |
| Sep 30, 2024 | 23.98% |
| Jun 30, 2024 | 25.75% |
| Mar 31, 2024 | 22.20% |
| Dec 31, 2023 | 20.88% |
| Sep 30, 2023 | 19.36% |
| Jun 30, 2023 | 18.86% |
| Mar 31, 2023 | 16.73% |
| Dec 31, 2022 | 17.01% |
| Sep 30, 2022 | 15.76% |
| Jun 30, 2022 | 13.74% |
| Mar 31, 2022 | 20.04% |
| Dec 31, 2021 | 21.01% |
| Sep 30, 2021 | 23.65% |
| Jun 30, 2021 | 27.31% |
| Mar 31, 2021 | 22.14% |
| Dec 31, 2020 | 25.42% |
| Sep 30, 2020 | 27.51% |
| Jun 30, 2020 | 19.60% |
| Mar 31, 2020 | 14.25% |
| Dec 31, 2019 | 16.33% |
| Sep 30, 2019 | 20.29% |
| Jun 30, 2019 | 20.06% |
| Mar 31, 2019 | 15.57% |
| Dec 31, 2018 | 25.34% |
| Sep 30, 2018 | 19.09% |
| Jun 30, 2018 | 42.71% |
| Mar 31, 2018 | 18.70% |
| Dec 31, 2017 | 24.17% |
| Sep 30, 2017 | 20.36% |
| Jun 30, 2017 | 21.50% |
| Mar 31, 2017 | 17.37% |
| Dec 31, 2016 | 16.79% |
| Sep 30, 2016 | 23.02% |
| Jun 30, 2016 | 16.90% |
| Mar 31, 2016 | 16.29% |
| Dec 31, 2015 | 15.08% |
| Sep 30, 2015 | 17.46% |
| Jun 30, 2015 | 14.04% |
| Mar 31, 2015 | 12.19% |
| Dec 31, 2014 | 14.66% |
| Sep 30, 2014 | 10.58% |
| Jun 30, 2014 | 10.90% |
| Mar 31, 2014 | -1.38% |
| Dec 31, 2013 | 6.54% |
| Sep 30, 2013 | 5.07% |
| Jun 30, 2013 | 6.05% |
| Mar 31, 2013 | 3.58% |
| Dec 31, 2012 | 5.17% |
| Sep 30, 2012 | 5.72% |
| Mar 31, 2012 | 4.88% |
| Dec 31, 2011 | 1.49% |
| Sep 30, 2011 | 5.22% |
| Jun 30, 2011 | 4.27% |
| Mar 31, 2011 | -0.21% |
| Dec 31, 2010 | -8.97% |
| Sep 30, 2010 | 14.88% |
| Jun 30, 2010 | 14.18% |